ir.inflibnet.ac.in
IR @ INFLIBNET: Home
Welcome to Institutional repository of INFLIBNET Centre, here you can find articles published in all conventional proceedings of INFLIBNET Centre, More over you can also look for various training material,press clippings,news letters etc. Choose a community to browse its collections. INFLIBNET in Press and Media. Murthy, T A V. Sinha, Manoj Kumar. Singh, Sanjay Kumar. Bhandi, M K.
ir.infoblox.com
Investor Relations | Infoblox
Click Here for Archived Webcast. 160; 0.09. Data as of 08/07/15 4:00 pm ET. Infoblox Extends Its Enterprise-Grade Network Services to the AWS Cloud. Infoblox Introduces 6Map, A Free Tool for Getting Started with IPv6. Infoblox Reports Third Quarter of Fiscal 2015 Results. Infoblox Introduces the Most Comprehensive Single-vendor Solution for Securing DNS Inside Enterprise Networks. There are currently no events scheduled. Data Provided by Thomson Reuters. Minimum 20 minutes delayed.
ir.information-publishing-system.de
information-publishing-system.de
The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).
ir.inlandrealestate.com
IRWeblink
Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.
ir.innophos.com
Investor Relations | Innophos Holdings, Inc.
Skip to main navigation. Innophos is a global specialty ingredients provider with:. An attractive EBITDA profile, and. 725m of revenue in 2016. We have a strong, clearly defined vision for the future called Vision 2022. To deliver on our Vision 2022 goals. Annual revenues: $725 million (FY 2016). Total assets: $643 million (FY 2016). Employs approximately 1,400 people worldwide. Acquired Novel Ingredients in August 2017 and NutraGenesis in November 2017. Innophos IPO date: November 2, 2006.
ir.inotekpharma.com
Investor Overview - Investors - Inotek Pharmaceuticals
Stock Quote and Chart. Inotek Pharmaceuticals Top-line MATrX-1 Results Conference Call. 160;at 8:30 am ET. Inotek Pharmaceuticals Top-line MATrX-1 Results Conference Call. Tuesday, January 3, 2017 . 8:30 am ET . Click here for webcast. Click here to add this event to your calendar. 160;- 0.03. Data as of 01/12/17 4:00 pm ET. Data provided by Nasdaq. Minimum 15 minute delay. Jan 3, 2017. Inotek Announces Top-line Results for MATrX-1, First Phase 3 Trial of Trabodenoson for Glaucoma. Nov 10, 2016.
ir.inovio.com
Inovio Pharmaceuticals - Investors - Overview
Inovio In The News. Investor News and Media. Financial Reports and Filings. Quarterly and Annual Reports. Code of Business Conduct and Ethics. Board Committee Composition and Charters. Contact the Board of Directors. Investigator Conflict of Interest Policy. Inovio is revolutionizing the fight against cancer and infectious diseases. Inovio Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call August 10, 2015. 2Q 2015 Financial Results Conference Call. August 10, 2015. 660 West Ger...
ir.inspirepharm.com
Non-Existent Domain
Your browser does not support iframes, please click here.
ir.intai.com.tw
鐿鈦科技 INTAI
Sp@mail.intai.com.tw.
ir.integrysgroup.com
IRWeblink
Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.
